Rockwell Medical, Inc.
General ticker "RMTI" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $39.1M (TTM average)
Rockwell Medical, Inc. does not follow the US Stock Market performance with the rate: -24.8%.
Estimated limits based on current volatility of 6.4%: low 5.02$, high 5.71$
Factors to consider:
- Total employees count: 157 (-35.7%) as of 2025
- Top business risk factors: Market competition, Regulatory and compliance, Economic downturns and volatility, Supply chain disruptions, Manufacturing disruptions
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.01$, 11.22$]
- 2026-12-31 to 2027-12-31 estimated range: [4.10$, 9.44$]
Financial Metrics affecting the RMTI estimates:
- Positive: with PPE of -12.1 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.12 <= 0.28
- Positive: Shareholder equity ratio, % of 64.71 > 64.23
Short-term RMTI quotes
Long-term RMTI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $83.61MM | $101.49MM | $69.26MM |
| Operating Expenses | $90.28MM | $100.88MM | $73.95MM |
| Operating Income | $-6.67MM | $0.61MM | $-4.69MM |
| Non-Operating Income | $-1.77MM | $-1.09MM | $-0.62MM |
| Interest Expense | $2.30MM | $1.25MM | $1.12MM |
| R&D Expense | $1.11MM | $0.02MM | $0.00MM |
| Income(Loss) | $-8.44MM | $-0.48MM | $-5.31MM |
| Net Income(Loss)* | $-8.44MM | $-0.48MM | $-5.31MM |
| Stockholders Equity | $21.29MM | $32.59MM | $36.98MM |
| Inventory | $5.87MM | $5.78MM | $3.42MM |
| Assets | $52.17MM | $59.21MM | $57.15MM |
| Operating Cash Flow | $-9.41MM | $4.20MM | $-0.66MM |
| Capital expenditure | $0.28MM | $1.01MM | $0.54MM |
| Investing Cash Flow | $-3.04MM | $-4.87MM | $-8.54MM |
| Financing Cash Flow | $11.34MM | $7.35MM | $4.25MM |
| Earnings Per Share** | $-3.62 | $-0.15 | $-1.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.